Dishman Carbogen Amcis Limited (NSE:DCAL)
196.93
+1.08 (0.55%)
Jul 13, 2026, 3:30 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 30.88 billion as of July 13, 2026. Its market cap has decreased by -19.22% in one year.
Market Cap
30.88B
Enterprise Value
51.56B
Revenue
29.32B
Ranking
n/a
PE Ratio
31.66
Stock Price
196.93
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 30.88B, a decrease of -45.66%. That is a compound annual growth rate of -6.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 30.88B | -20.46% |
| Dec 31, 2025 | 38.82B | -8.46% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 677.29B |
| Anthem Biosciences | 425.04B |
| OneSource Specialty Pharma | 186.52B |
| Concord Biotech | 136.49B |
| Blue Jet Healthcare | 108.25B |
| Supriya Lifescience | 68.78B |
| Zota Health Care | 49.28B |
| Panacea Biotec | 33.48B |